Risk management profile of etoricoxib: an example of personalized medicine
about
Current perspectives in NSAID-induced gastropathyAn Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and DiseasesMusculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review.Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.Evolution to low-dose NSAID therapy.Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage.
P2860
Risk management profile of etoricoxib: an example of personalized medicine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk management profile of etoricoxib: an example of personalized medicine
@en
Risk management profile of etoricoxib: an example of personalized medicine.
@nl
type
label
Risk management profile of etoricoxib: an example of personalized medicine
@en
Risk management profile of etoricoxib: an example of personalized medicine.
@nl
prefLabel
Risk management profile of etoricoxib: an example of personalized medicine
@en
Risk management profile of etoricoxib: an example of personalized medicine.
@nl
P2093
P2860
P356
P1476
Risk management profile of etoricoxib: an example of personalized medicine
@en
P2093
Marta L Capone
Paola Patrignani
Stefania Tacconelli
P2860
P304
P356
10.2147/TCRM.S3209
P577
2008-10-01T00:00:00Z